Apatinib remodels the immunosuppressive tumor ecosystem of gastric cancer enhancing anti-PD-1 immunotherapy
Open Access
- 27 April 2023
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 42 (5) , 112437
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Fujian Province (2019-ZQNB-28, 2019J01555, 2020J01106, 2020J011207, 2021J011328)
- Illinois Humanities
- Xiamen City Department of Science and Technology (3502Z20194017, 3502Z20214ZD1030)
- National Natural Science Foundation of China (41906089, 81602148, 81872422, 81902543)
This publication has 57 references indexed in Scilit:
- New horizons in tumor microenvironment biology: challenges and opportunitiesBMC Medicine, 2015
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer ResearchCancer Discovery, 2014
- Treatment of gastric cancerWorld Journal of Gastroenterology, 2014
- Tumor metastasis: moving new biological insights into the clinicNature Medicine, 2013
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- T-cell death and cancer immune toleranceCell Death & Differentiation, 2007
- Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) is an Independent Prognostic Indicator of Worse Outcome in Gastric Cancer PatientsAnnals of Surgical Oncology, 2007
- Life and death in peripheral T cellsNature Reviews Immunology, 2007
- CXCL5 overexpression is associated with late stage gastric cancerJournal of Cancer Research and Clinical Oncology, 2007
- NF-κB, chemokine gene transcription and tumour growthNature Reviews Immunology, 2002